Zydus Lifesciences Secures USFDA Tentative Approval For Dapagliflozin Tablets

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Zydus Lifesciences Ltd has received tentative approval from the US Food and Drug Administration for Dapagliflozin tablets in 5 mg and 10 mg strengths. The approval allows the company to market the product in the US once patent and exclusivity conditions are resolved.